Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05895006 · ClinicalTrials.gov registry record · NA
A Neurosensory Account of Anxiety and Stress (Study 1)
A NA study of Posttraumatic Stress Disorder (PTSD) and Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05895006 is a NA study of Posttraumatic Stress Disorder (PTSD) and Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 160 participants, above the 106-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05895006, a NA study of Posttraumatic Stress Disorder (PTSD) and Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.
Conditions Studied
Interventions
- DEVICE Sham for Transcranial Alternating Current Stimulation (tACS)
- DEVICE Transcranial Random Noise stimulation (tRNS)
- DEVICE Alternating Current Stimulation (tACS)
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05895006
The ClinicalTrials.gov registry entry for NCT05895006 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 106-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (51% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 3 interventions - of which Sham for Transcranial Alternating Current Stimulation (tACS) is the first listed.
NCT05895006 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05895006 about?
NCT05895006 is a clinical study titled "A Neurosensory Account of Anxiety and Stress (Study 1)". This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arous...
What is the current status of trial NCT05895006?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2022-04-05. Estimated completion is 2026-12-31.
What conditions does trial NCT05895006 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD), Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition.
What interventions are being tested in trial NCT05895006?
The interventions under investigation include: Sham for Transcranial Alternating Current Stimulation (tACS) (DEVICE), Transcranial Random Noise stimulation (tRNS) (DEVICE), Alternating Current Stimulation (tACS) (DEVICE).
Who is sponsoring clinical trial NCT05895006?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05895006 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder (PTSD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
A Neurosensory Account of Anxiety and Stress (Study 2)
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women
RECRUITING · NA
-
Integrated Treatment for Opioid Use Disorder and PTSD
RECRUITING · NA
-
Open Pilot Trial of Adapted Cognitive Processing Therapy for Comorbid PTSD and Opioid Use Disorder
RECRUITING · NA
Explore more on PlainTrial
Posttraumatic Stress Disorder (PTSD)
All registered trials for this condition
Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.